<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Villarreal Cameron | Activity</title>
	<link>http://toxicdolls.com/members/shelfnote9/activity/</link>
	<atom:link href="http://toxicdolls.com/members/shelfnote9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Villarreal Cameron.</description>
	<lastBuildDate>Sat, 02 May 2026 12:18:40 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">96c0f693f615ce8f98e8720f93b3b71e</guid>
				<title>Villarreal Cameron posted an update: In ezdirect withdrew approval for all commercially [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/187057/</link>
				<pubDate>Thu, 05 Feb 2026 15:35:51 +0000</pubDate>

									<content:encoded><![CDATA[<p>In ezdirect withdrew approval for all commercially manufactured oxandrolone tablets (Oxandrin® and generics) because of safety and efficacy concerns, so patient-specific compounding is now the sole legal supply route. Additional absolute contraindications include nephrosis, the nephrotic phase of nephritis, and hypersensitivity to oxandrolone or&hellip;<span class="activity-read-more" id="activity-read-more-187057"><a href="http://toxicdolls.com/activity-2/p/187057/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">af80ca4ca3fe42827932e5762fd55ab1</guid>
				<title>Villarreal Cameron became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/187022/</link>
				<pubDate>Thu, 05 Feb 2026 15:24:32 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>